Ingredient intelligence

Zinc oxide

Mineral · Zinc Oxide · ZnO

Zinc oxide is an inorganic UV filter. Its protective mechanism is physical and chemical attenuation of UV photons rather than a biological pathway.

Molecular identity

Two-dimensional chemical structure of Zinc oxide
Formula
ZnO
Molecular weight
81.38 g/mol
PubChem CID
14806
ChEBI
CHEBI:36560
Open PubChem record →

Biological targets

  • UV photons (physical attenuation)

    high confidence

    inhibits · complex

    Not a protein target.

Molecules & genes

Molecules

  • Zinc oxideZnO · 81.38 g/mol

Genes / proteins

How could this ingredient interact with biology?

Biological network

Ingredient → molecule → target → gene/protein → pathway → process → studied outcome. Relationship strength is drawn from the curated confidence tier; nothing is added to make the chain look complete.

100%
Zinc oxideZinc oxideUV photons (physical atte…DNA damage response (UV-i…UV photoprotectionOxidative stress responseUV filters are the best-s…

drag to pan · hover to isolate a path · click a node for detail

IngredientMoleculeTargetGenePathwayProcessOutcome

2 lower-confidence relationships are hidden at this filter level. Use “Show more biology” to include them.

Text alternative for this network
  • Zinc oxide is molecule Zinc oxidehigh confidence
  • Zinc oxide inhibits UV photons (physical attenuation)high confidence
  • DNA damage response (UV-induced) associated with UV photoprotectionmedium confidence
  • DNA damage response (UV-induced) associated with Oxidative stress responsemedium confidence
  • UV photoprotection studied in UV filters are the best-supported intervention for photoaging preventionhigh confidence
  • Oxidative stress response studied in UV filters are the best-supported intervention for photoaging preventionmedium confidence

Biological pathways

DNA damage response (UV-induced)

medium confidence

Reducing UV dose reduces downstream photolesion signalling.

Reactome R-HSA-73893

Evidence engine

Moderate

Some human evidence exists, but replication or sample sizes are limited.

Skinceptor Evidence Index

60

experimental · of 100

This index is a research-navigation aid describing how much evidence exists and how it was produced. It is not a medical safety score, an efficacy guarantee, or a clinical recommendation.

Study composition

  • Randomised controlled trial1
Total studies
1
Human studies
1
Largest sample
903
Range
2013–2013

Index breakdown

  • Study design quality90% × 28%

    Mean design weight across curated studies (meta-analysis 1.0, RCT 0.9, other human 0.7, review 0.45, animal 0.35, in-vitro 0.25).

  • Human evidence share33% × 22%

    Proportion of curated evidence measured in people rather than cells or animals.

  • Evidence volume32% × 14%

    Log-scaled count of curated studies, so volume alone cannot dominate the score.

  • Largest sample size99% × 12%

    Log-scaled largest reported sample size across curated human studies.

  • Replication33% × 12%

    Independent human studies, capped at three; one study is never treated as replicated.

  • Recency35% × 7%

    Linear decay over a twenty-year window from the most recent curated publication.

  • Source traceability100% × 5%

    Share of curated studies with a verified PMID or DOI in this dataset.

How is this determined? →

Insufficient comparable evidence for quantitative synthesis.

Research timeline

How the evidence accumulated

  1. 2013

    Daily sunscreen use and skin ageing: a randomised trial

    Randomised controlled trialn = 903 · Annals of Internal Medicine

Ingredient fingerprint

9 nodes · 10 relationships · seed "zinc-oxide"

The fingerprint is a deterministic visual signature: ridge amplitude comes from the number of entities in each tier, node placement from identifier hashes, and opacity from confidence. Two ingredients can never produce the same figure unless their networks are identical.

Open in Biology as Art →

Research

1 curated study

Randomised controlled trialAnnals of Internal Medicine · 2013n = 903

Daily sunscreen use and skin ageing: a randomised trial

Reported no detectable increase in skin ageing over 4.5 years in the daily sunscreen group compared with discretionary use.

LimitationsSunscreen formulation was not zinc-oxide-specific; outcome assessed by microtopography of the hand.

PMID 23732711Zinc oxide

Community evidence

Submitted by readers

Submit a study

Reader submissions appear here only after review. They are not part of the curated dataset and do not affect the Skinceptor Evidence Index.

No approved community submissions yet.

Sources